Thermo Fisher Scientific Inc. (ETR:TN8)
Germany
· Delayed Price · Currency is EUR 343.50
-1.40 (-0.41%)
Jun 25, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Life Sciences Solutions | 9.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Solutions Growth | 0.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Analytical Instruments | 7.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Analytical Instruments Growth | 3.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Diagnostics | 4.55B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Diagnostics Growth | 3.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Products and Biopharma Services | 23.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Products and Biopharma Services Growth | 0.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumables | 17.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumables Growth | 1.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Instruments | 7.45B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Instruments Growth | 0.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services | 17.84B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services Growth | 0.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Life Sciences Solutions Operating Income | 3.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Solutions Operating Income Growth | 2.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Analytical Instruments Operating Income | 1.96B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Analytical Instruments Operating Income Growth | 3.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Diagnostics Operating Income | 1.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Diagnostics Operating Income Growth | 2.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Products and Biopharma Services Operating Income | 3.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Products and Biopharma Services Operating Income Growth | -7.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| North America | 22.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | -0.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 10.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 0.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia-Pacific | 7.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia-Pacific Growth | 3.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Regions | 1.55B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Regions Growth | 4.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| Total Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Core Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|